[Effects of SL-1010 (sodium hyaluronate with high molecular weight) on experimental osteoarthritis induced by intra-articularly applied papain in guinea pigs].
Effects of SL-1010 on the experimental osteoarthritis (OA) produced by intra-articular injection of papain, proteolytic enzyme, in the knee joint of the guinea pigs were histologically and biochemically investigated. In addition, experimental conditions to produce OA in guinea pig knee joint were also examined, since papain-induced OA has been mainly studied in rabbits. Six weeks after intra-articular injection of papain (1%, 0.1 ml), there were inflammatory reactions of the synovial membrane, degenerative changes in chondrocytes and the matrix of the articular cartilage, a decrease in the Safranin-O staining intensity and lowering of sulfated glycosaminoglycan. Electronmicroscopic observations revealed that the amorphous layer had disappeared and large bundles of unit collagen fibers and larger collagen fibers had appeared in the cartilage matrix. In the OA model, SL-1010 reduced the inflammatory reactions of the synovial membrane, inhibited development of degenerative changes in chondrocytes and the matrix of the articular cartilage and recovered the Safranin-O staining intensity. The sulfated glycosaminoglycan contents in the cartilage was significantly increased in the SL-1010-treated group, compared with the control group. The electromicroscopically observed charges in the papain-injected knee joint of the control group were rarely detected in the SL-1010-treated group. These results suggest that SL-1010 inhibits degenerative changes in the chondrocytes and the matrix probably by reducing synovial inflammation and protection of the cartilage in the OA model of guinea pigs.
Tanaka
H
H
Hikone Research Laboratories, MARUHO, Co., Ltd., Shiga, Japan.
Kitoh
Y
Y
Katsuramaki
T
T
Tanaka
M
M
Kitabayashi
N
N
Fujimori
S
S
Umemoto
J
J
Namba
K
K
D000818:Animals; D002358:Cartilage, Articular / Q000737:chemistry / Q000187:drug effects* / Q000473:pathology; D005260:Female; D006025:Glycosaminoglycans / Q000032:analysis*; D006168:Guinea Pigs; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D007270:Injections, Intra-Articular; D007719:Knee Joint / Q000473:pathology; D008854:Microscopy, Electron; D008970:Molecular Weight; D010003:Osteoarthritis / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D010206:Papain / Q000008:administration & dosage / Q000494:pharmacology
D006025:Glycosaminoglycans; C013786:A73025; D006820:Hyaluronic Acid; D010206:Papain